Patient and Caregiver
Investigator
Regulator
IRB
Tech, Device,
PayerTrial Design Stage
Published Date: April 29, 2025
Share to:
Helpful Terms and Definitions
*This list is not exhaustive, nor does CTTI officially endorse the resources created by other organizations.
Final Protocol
What study metrics (e.g., enrollment progress, data quality, retention) can be shared across sites to support alignment and motivate site teams?
Questions To Ask
- How will study data be collected, stored, and managed across sites?
- How does site size and available personnel impact study execution?
- Do all participating sites have comparable resources and capabilities?
- What support or infrastructure is needed to ensure consistent execution across sites?
Why involve investigators and sites now?
At the final protocol stage, investigators and site teams play a critical role in confirming readiness for study execution.
Active engagement at this stage enables sites to:
- Plan for enrollment, retention, and protocol compliance
- Prepare for data entry, query resolution, and operational oversight
- Clarify expectations prior to activation
- Complete training and integrate study workflows
- Build momentum ahead of study launch
This stage closes the loop on earlier site identification and feasibility efforts, ensuring selected sites are fully prepared and aligned.
It supports:
- Realistic operational planning
- Achievement of diversity and inclusion goals
- Stronger collaboration across community and academic sites
- Consistent execution once the study begins
Sponsors that maintain strong engagement at this stage typically see smoother study startup and more consistent study conduct.
What aspects of the final protocol should they inform?
At this stage, input focuses on final validation and implementation readiness, rather than design changes:
- Operational feasibility of visit schedules and procedures
- Participant burden and recruitment considerations
- Clarity of procedures, timing, and site instructions
- Barriers to participation for diverse and underrepresented populations
- Implementation of protocol amendments
All amendments—regardless of size—should be communicated clearly and promptly to maintain alignment across sites.
How can I build a feedback loop with investigators and sites?
A structured feedback loop allows sites to raise operational concerns without reopening core scientific design decisions.
What should sponsors do at the final protocol stage?
Distribute the Final Protocol
Ensure all sites receive the same approved version to maintain consistency and reduce variability in execution
Conduct study kickoff meetings and training
Align site teams and internal functions (e.g., safety, data management)
Examples:
- Investigator meetings or webinars
- Protocol walkthroughs
- Technology platform training
- Clinical procedure and assessment training
- Safety reporting and adverse event training
Communicate expectations clearly
Provide concise guidance on:
- Startup timelines
- Data entry expectations
- Safety reporting requirements
- Document submission
- Scheduling of initiation visits
Establish rapid response and escalation pathways
Ensure sites know exactly how to escalate urgent issues to the sponsor or CRO
- Define clear contacts and communication channels
- Enable rapid issue resolution to prevent broader study impact
Example:
If a critical-to-quality (CTQ) factor (e.g., a complex imaging requirement) is affecting patient participation, sites should escalate quickly so mitigation strategies can be implemented.